DOCSLIB.ORG

A Rare Case of Peripheral Cone Dystrophy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Angela Shahbazian Case Report Proposal American Academy of Optometry: Residents Day A Rare Case of Peripheral Cone Dystrophy We present a rare variation of cone dystrophy presenting with normal vision, mild color defects, paracentral scotomas, paracentral retinal thinning, and normal-appearing fundus. No longitudinal reports exist in literature, but four-year follow-up indicates relative stability. I. Case History • Patient Demographics o 26 year old Korean/Caucasian male presents for annual eye exam. • Chief Complaint o Blur at distance without glasses. o No other visual complaints. o No complaints of hemeralopia, nyctalopia, or photophobia. • Ocular History o Myopia and astigmatism only. • Family Ocular History o No history of eye disease or reduced vision in extended family. o Patient has no siblings. • Medical History o Unremarkable with no systemic diseases. • Medications o None. II. Pertinent findings • Best-corrected visual acuity 20/20 OD, OS. • All confrontation testing is normal. • Anterior segment findings are normal. • Color vision with HRR plates and standard illuminant C: o OD: mild indeterminate red-green defect, moderate tetartan (blue-yellow) defect. o OS: mild indeterminate red-green and blue-yellow defect. • Dilated fundus exam reveals normal-appearing fundus OU aside from mild temporal pallor of the optic disc OS. • Visual field testing: o Initial FDT screening field: symmetric paracentral scotomas OD, OS. o Three subsequent HVF 30-2 visual fields: confirmed paracentral scotomas OD, OS. o HVF 30-2 four years later: no clear progression of visual field loss OD, OS. o Baseline HVF 10-2 four years later: symmetric paracentral scotomas up to 4 degrees from fixation OD, OS. • Macular OCT: o Paracentral retinal thinning corresponding to location of visual field defects in both eyes, with slightly more thinning OD. Raster scan reveals no loss of any retinal layers and intact EZ/IZ lines in both eyes. o Macular OCTs four years later: no progression of retinal thinning in both eyes. • Fundus autofluorescence: o Symmetric subtle hyperfluorescence in nasal perimacular area OD, OS • Full-field ERG and mfERG have been ordered. Results will be included in the poster. III. Differential diagnosis • Peripheral cone dystrophy • Occult Macular dystrophy • Cone-rod dystrophy • Toxic retinopathy • Oligocone trichromacy • Retinitis pigmentosa IV. Diagnosis and discussion • Peripheral cone dystrophy is a rare cone dystrophy characterized by: 1 o Visual acuity normal to slightly reduced § 20/50 or better in all patients under 75 years of age without comorbidities 1 o Normal-to-slightly reduced color vision 2 o Paracentral scotomas 3,4 o Paracentral retinal thinning with no loss of retinal layers as observed on OCT 2,3,4,5 o Normal fundus appearance aside from mild temporal pallor in some cases o Full-field electroretinogram (ERG) 2 § Scotopic ERG: normal rod function 2 § Photopic ERG: severely reduced cone function o Multifocal ERG 2 § Slightly detectable to near-normal response in macular area 2 § Severely reduced peripheral amplitudes 2 o Subtle parafoveal hyperfluorescence as observed in fundus autofluorescence 2 o Normal fluorescein angiography • Visual symptoms commonly include hemeralopia and photophobia. • It is considered a subgroup of cone dystrophy, and only ten cases have been reported in the literature to date. • Compared to other cone dystrophies, peripheral cones are predominantly affected resulting in normal-to-slightly-reduced color vision and better visual acuities.5 • Autosomal recessive inheritance has been suggested, but there are no known causative genes. • Disease progression is largely unknown due to the small number of reported cases, variance of disease presentation at older age, and no case reports following patients over the course of several years.6,7 V. Treatment, management • Full-field ERG and multifocal ERG required for definitive diagnosis. • Educate the patient: o The condition is inherited. o There are no known treatments for this specific condition at this time. o Final visual outcome is not fully known because this condition is so rare. • Monitor visual function with HVF 10-2 fields and Macular OCT for any progression of visual field defects or further retinal thinning. VI. Conclusion • Clinical Pearls o Fundus autofluorescence is a helpful tool in highlighting subtle retinal disease, including various cone dystrophies, that may not be detectable on fundus exam. o Peripheral cone dystrophy is a rare subgroup of cone dystrophy that predominantly affects peripheral cones, and therefore has different symptoms and clinical signs than other cone dystrophies. o Macular OCT can be a helpful tool in diagnosing peripheral cone dystrophy and in monitoring disease progression. o Long-term prognosis for peripheral cone dystrophy is unclear due to limited number of reported cases. Bibliography: 1. Vaphiades MS, Doyle JI. Peripheral Cone Dystrophy : A Diagnostic Improbability ? J Neuroophthalmol. 2014;(34):366-368. doi:10.1097/WNO.0000000000000119. 2. Ito N, Kameya S, Gocho K, et al. Multimodal imaging of a case of peripheral cone dystrophy. Doc Ophthalmol. 2015;130(3):241-251. doi:10.1007/s10633-015-9490-1. 3. Baek J, Lee H-K, Kim US. Spectral domain optical coherence tomography findings in bilateral peripheral cone dystrophy. Doc Ophthalmol. 2013;126(3):247-251. doi:10.1007/s10633-013-9377-y. 4. Mochizuki Y, Shinoda K, Matsumoto CS, et al. Case of unilateral peripheral cone dysfunction. Case Rep Ophthalmol. 2012;3(2):162-168. doi:10.1159/000339129. 5. Kondo M, Miyake Y, Kondo N, Ueno S, Takakuwa H, Terasaki H. Peripheral cone dystrophy: A variant of cone dystrophy with predominant dysfunction in the peripheral cone system. Ophthalmology. 2004;111(4):732-739. doi:10.1016/j.ophtha.2003.07.005. 6. Sakuramoto H, Kuniyoshi K, Tsunoda K, Akahori M, Iwata T, Shimomura Y. Two siblings with late-onset cone-rod dystrophy and no visible macular degeneration. Clin Ophthalmol. 2013;7:1703-1711. doi:10.2147/OPTH.S48723. 7. Okuno TT, Oku H, Kurimoto T, Oono S, Ikeda T. Peripheral cone dystrophy in an elderly man. Clin Exp Ophthalmol. 2008;36(9):897-899. doi:10.1111/j.1442-9071.2008.01905.x. .
Recommended publications
  • Rod-Cone Dystrophy Associated with the Gly167asp Variant in PRPH2

    Rod-Cone Dystrophy Associated with the Gly167asp Variant in PRPH2

    Rod-cone dystrophy associated with the Gly167Asp variant in PRPH2 Rola Ba-Abbad, FRCS, PhD1,2, Anthony G. Robson, PhD1,2, Becky MacPhee, BSc2, Andrew R. Webster, MD(Res), FRCOpth1,2, Michel Michaelides, MD(Res), FRCOphth 1,2 1. UCL Institute of Ophthalmology, University College London, London, UK 2. Moorfields Eye Hospital, London, UK Declaration of interest statement: the authors report no conflict of interest. Corresponding Author: Professor Michel Michaelides, MD(Res), FRCOphth UCL Institute of Ophthalmology, London, EC1V 9EL, United Kingdom Email: [email protected] Phone number: +44 (0) 20 7608 6800 Peripherin 2-associated retinopathies are phenotypically heterogenous and can present as autosomal dominant retinitis pigmentosa, cone-rod dystrophy, various forms of macular and pattern dystrophy, or recessive retinopathy1,2. We report a case of rod-cone dystrophy associated with the variant c.500G>A, p.(Gly167Asp) in PRPH2 (OMIM 179605), which was previously reported to cause autosomal dominant butterfly-shaped pigment dystrophy of the fovea in a three-generation pedigree (MIM 169150)3. A 66-year old British woman of European ancestry was referred to the inherited retinal disorders clinic with bilateral pigmentary retinopathy, and a 5-year history of nyctalopia. There were no knowingly affected family members; her late father and mother had normal vision in their sixties and eighties respectively, and the patient’s two children had no symptoms in their third decade of life. Previously, she underwent laser refractive surgery for myopia, bilateral cataract extraction and laser posterior capsulotomy. On examination, the Snellen visual acuity was 20/30 in the right eye, and 20/80 in the left eye; and color vision (Ishihara plates) was normal bilaterally.
  • Genes in Eyecare Geneseyedoc 3 W.M

    Genes in Eyecare Geneseyedoc 3 W.M

    Genes in Eyecare geneseyedoc 3 W.M. Lyle and T.D. Williams 15 Mar 04 This information has been gathered from several sources; however, the principal source is V. A. McKusick’s Mendelian Inheritance in Man on CD-ROM. Baltimore, Johns Hopkins University Press, 1998. Other sources include McKusick’s, Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore. Johns Hopkins University Press 1998 (12th edition). http://www.ncbi.nlm.nih.gov/Omim See also S.P.Daiger, L.S. Sullivan, and B.J.F. Rossiter Ret Net http://www.sph.uth.tmc.edu/Retnet disease.htm/. Also E.I. Traboulsi’s, Genetic Diseases of the Eye, New York, Oxford University Press, 1998. And Genetics in Primary Eyecare and Clinical Medicine by M.R. Seashore and R.S.Wappner, Appleton and Lange 1996. M. Ridley’s book Genome published in 2000 by Perennial provides additional information. Ridley estimates that we have 60,000 to 80,000 genes. See also R.M. Henig’s book The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, published by Houghton Mifflin in 2001 which tells about the Father of Genetics. The 3rd edition of F. H. Roy’s book Ocular Syndromes and Systemic Diseases published by Lippincott Williams & Wilkins in 2002 facilitates differential diagnosis. Additional information is provided in D. Pavan-Langston’s Manual of Ocular Diagnosis and Therapy (5th edition) published by Lippincott Williams & Wilkins in 2002. M.A. Foote wrote Basic Human Genetics for Medical Writers in the AMWA Journal 2002;17:7-17. A compilation such as this might suggest that one gene = one disease.
  • DJO Macular Dystrophy in a Post LASIK Patient

    DJO Macular Dystrophy in a Post LASIK Patient

    DJO Vol. 30, No. 3, January-March 2020 Case Report Macular Dystrophy in a Post LASIK Patient Sanjana Vatsa, Shana Sood Dr. Agarwal Eye Hospital, Chennai, Tamil Nadu, India LASIK (Laser Assisted Insitu keratomileusis) is the most commonly performed refractive surgery worldwide. A detailed pre operative and post operative evaluation of the anterior and posterior segment is a must. A 35 year old male patient with a history of LASIK surgery done 13 years back presented to us with complaint of painless, progressive diminution of vision in both eyes from past Abstract 2 years. Dilated retinal examination showed bulls eye maculopathy in both eyes. Macular OCT showed gross reduction in central foveal thickness. ERG showed marked reduction in photopic responses suggestive of a cone dystrophy. Treatment aims at alleviating the symptoms and use of low vision aids. Genetic counselling may be of benefit for affected individuals and their families. Delhi J Ophthalmol 2020;30;60-62; Doi http://dx.doi.org/10.7869/djo.529 Keywords: LASIK, Bulls eye maculopathy, cone dystrophy, genetic counselling. Introduction LASIK is the most popular and commonly performed refractive surgery worldwide.1 Along with anterior segment, a detailed evaluation of the posterior segment is a must on follow up visits to rule out any retinal lesions such as degenerations, dystrophies, maculopathy etc; as these can occur irrespective of any procedure performed. Case Report A 35 year old male patient came to us with a history of LASIK surgery done 13 years back in both eyes for a power of -7.0D sphere. Patient was comfortable with his vision after surgery and had no complaints for 11 years, after which he noticed blurring of vision in both eyes (more in the left eye).
  • The Role of Erg/Vep and Eye Movement Recordings in Children with Ocular Motor Apraxia

    The Role of Erg/Vep and Eye Movement Recordings in Children with Ocular Motor Apraxia

    THE ROLE OF ERG/VEP AND EYE MOVEMENT RECORDINGS IN CHILDREN WITH OCULAR MOTOR APRAXIA FATIMA S. SHAWKAT, CHRISTOPHER M. HARRIS, DAVID S. I. TAYLOR and ANTHONY KRISS London SUMMARY several reports of OMA or saccade failure occurring Ocular motor apraxia (OMA) is characterised by an congenitally, with no other clinical entity?-5 How­ intermittent inability to initiate voluntary sacca des, and ever, it can also occur as part of a wider neurological a failure to produce optokinetic and vestibular quick disorder: for example with structural brain abnorm­ phases. Some patients have no other abnormalities alities, such as agenesis of the corpus callosum6 and (idiopathic OMA), whereas in others it appears vermis hypoplasia;7 with neurodegenerative condi­ associated with a variety of neurological conditions tions;8 and with acquired neurological disease such as which may affect the sensory visual pathway. Electro­ posterior fossa tumours,9 ataxia telangiectasia,lO retinograms (ERGs), flash and pattern visual evoked fronto-parietal lesions,l1.l2 occipital cortex lesions,13 potentials (VEPs) and eye movements were assessed in cerebellar and brains tern neoplasm14 and olivoponto­ 53 children with OMA (age range 17 days to 14 years) cerebellar degeneration. 15.16 The inability to gener­ to determine their efficacy in helping to distinguish ate saccades often leads to the development of between idiopathic and non-idiopathic cases. Seven patients (13.2%) had idiopathic OMA and the remain­ compensatory behaviour to shift direction of gaze; ing 46 (86.8%) had other associated clinical conditions. this includes headthrusting, blinking and tilted head All patients had episodes of absent quick phases ('lock posture, which enables the use of vertical eye up') during optokinetic nystagmus (OKN) and/or movements that are usually unaffected.
  • Progressive Cone and Cone-Rod Dystrophies

    Progressive Cone and Cone-Rod Dystrophies

    Br J Ophthalmol: first published as 10.1136/bjophthalmol-2018-313278 on 24 January 2019. Downloaded from Review Progressive cone and cone-rod dystrophies: clinical features, molecular genetics and prospects for therapy Jasdeep S Gill,1 Michalis Georgiou,1,2 Angelos Kalitzeos,1,2 Anthony T Moore,1,3 Michel Michaelides1,2 ► Additional material is ABSTRact proteins involved in photoreceptor structure, or the published online only. To view Progressive cone and cone-rod dystrophies are a clinically phototransduction cascade. please visit the journal online (http:// dx. doi. org/ 10. 1136/ and genetically heterogeneous group of inherited bjophthalmol- 2018- 313278). retinal diseases characterised by cone photoreceptor PHOTORECEPTION AND THE degeneration, which may be followed by subsequent 1 PHOTOTRANSDUCTION CASCADE UCL Institute of rod photoreceptor loss. These disorders typically present Rod photoreceptors contain rhodopsin phot- Ophthalmology, University with progressive loss of central vision, colour vision College London, London, UK opigment, whereas cone photoreceptors contain 2Moorfields Eye Hospital NHS disturbance and photophobia. Considerable progress one of three types of opsin: S-cone, M-cone or Foundation Trust, London, UK has been made in elucidating the molecular genetics L-cone opsin. Disease-causing sequence variants 3 Ophthalmology Department, and genotype–phenotype correlations associated with in the genes encoding the latter two cone opsins University of California San these dystrophies, with mutations in at least 30 genes
  • 2015 Scheidecker Bardet Biedt

    2015 Scheidecker Bardet Biedt

    Predominantly Cone-System Dysfunction as Rare Form of Retinal Degeneration in Patients With Molecularly Confirmed Bardet-Biedl Syndrome SOPHIE SCHEIDECKER, SARAH HULL, YAUMARA PERDOMO, FOUZIA STUDER, VALE´RIE PELLETIER, JEAN MULLER, CORINNE STOETZEL, ELISE SCHAEFER, SABINE DEFOORT-DHELLEMMES, ISABELLE DRUMARE, GRAHAM E. HOLDER, CHRISTIAN P. HAMEL, ANDREW R. WEBSTER, ANTHONY T. MOORE, BERNARD PUECH, AND HE´LE`NE J. DOLLFUS PURPOSE: To describe a series of patients with Bardet- with Bardet-Biedl syndrome. (Am J Ophthalmol Biedl syndrome (BBS) and predominantly retinal cone 2015;160(2):364–372. Ó 2015 by Elsevier Inc. All dysfunction, a previously only rarely reported association. rights reserved.) DESIGN: Retrospective observational case series. METHODS: Seven patients with clinically proven Bardet-Biedl syndrome had undergone detailed ocular ARDET-BIEDL SYNDROME IS AN EMBLEMATIC CILIOP- phenotyping, which included fundus examination, Gold- athy associated with severe and early-onset retinal mann visual fields, fundus autofluorescence imaging dystrophy, postaxial polydactyly, early obesity, renal B 1 (FAF), optical coherence tomography (OCT), and elec- dysfunction, hypogonadism, and learning difficulties. It is troretinography (ERG). Mutational screening in the genetically heterogeneous, with 20 BBS genes identified BBS genes was performed either by direct Sanger (BBS1 to BBS20)todate,2,3 all of which encode proteins sequencing or targeted next-generation sequencing. involved in the development and the maintenance of the RESULTS: All 7 patients had proven BBS mutations; 1 primary cilium. had a cone dystrophy phenotype on ERG and 6 had a The retinal dystrophy associated with Bardet-Biedl syn- cone-rod pattern of dysfunction. Macular atrophy was drome is usually severe but expression can be variable.
  • Case Report Sarah Burgett, OD Primary Care/Low Vision Resident Marion VAMC Marion, IL

    Case Report Sarah Burgett, OD Primary Care/Low Vision Resident Marion VAMC Marion, IL

    Case Report Sarah Burgett, OD Primary Care/Low Vision Resident Marion VAMC Marion, IL Abstract A 52 year-old African American male has experienced a gradual decrease in visual acuity from 2008 to present. Ocular exams are unremarkable aside from the decrease in visual acuity. Grossly abnormal ERG results confirm progressive cone-rod dystrophy. I. Case History -Patient demographics: 52 year-old African American male -Chief complaint: Vision continues to slowly decline OU. Patient reports increased difficulty reading the Bible and other small print. -Ocular history: Myasthenia gravis x 25 years s/p thymectomy 1985. binding antibody (+), blocking/modulating antibody (-). Presented with ocular symptoms, but has become systemic. Mestinon was tried for his ocular symptoms, but it didn’t help. The patient has been on prednisone since. Doing well on prednisone 10mg QOD x many years. Diplopia/ptosis well controlled at this point. Further tapering (below 5mg/day or 10mg QOD) has been unsuccessful. Patient is follow by Neurology at Marion VA. -Medical history: Hypertension, elevated cholesterol, and pulmonary problems -Medications: 1) Colestipol HCl 1GM TAB to lower cholesterol 2) Diltiazem 180MG SA CAP for heart and blood pressure 3) Fenofibrate 145MG TAB to lower cholesterol and triglycerides 4) Hydrochlorothiazide 25MG TAB for fluid and blood pressure 5) Hydrocodone 5/Acetaminophen 500MG TAB PRN for pain 6) Lisinopril 20MG TAB to lower blood pressure 7) Prednisone 10MG TAB for myasthenia gravis - Allergies: Niacin, Zocor, Pravastatin, Crestor, Zetia 10MG TAB, Lopid 600MG TAB II. Pertinent findings -Clinical: Progressively declining BCVA OU 08/2003 20/20 OD, 20/20 OS 11/2008 20/20 OD, 20/20 OS 04/2009 20/25 OD, 20/30 NIPH OS 06/2010 20/40 OD, 20/50 OS 09/2010 20/30 OD, 20/50-2 12/2010 20/30 OD, 20/60-2 Entrance testing, slit lamp, intraocular pressure, dilated fundus examination all within normal limits OU; no ocular manifestations of myasthenia gravis.
  • The Primate Model for Understanding and Restoring Vision

    The Primate Model for Understanding and Restoring Vision

    The primate model for understanding and restoring vision Serge Picauda,1, Deniz Dalkaraa,1, Katia Marazovaa, Olivier Goureaua, Botond Roskab,c,d,2, and José-Alain Sahela,e,f,g,2 aInstitut de la Vision, INSERM, CNRS, Sorbonne Université, F-75012 Paris, France; bInstitute of Molecular and Clinical Ophthalmology Basel, CH-4031 Basel, Switzerland; cFaculty of Medicine, University of Basel, 4056 Basel, Switzerland; dFriedrich Miescher Institute, 4058 Basel, Switzerland; eDepartment of Ophthalmology, The University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; fINSERM-Centre d’Investigation Clinique 1423, Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts, F-75012 Paris, France; and gDépartement d’Ophtalmologie, Fondation Ophtalmologique Rothschild, F-75019 Paris, France Edited by Tony Movshon, New York University, New York, NY, and approved October 18, 2019 (received for review July 8, 2019) Retinal degenerative diseases caused by photoreceptor cell death provide highly responsive and reliable models for in-depth are major causes of irreversible vision loss. As only primates have a functional studies. Furthermore, brain-imaging studies de- macula, the nonhuman primate (NHP) models have a crucial role scribing visual cortex activity aid our understanding of the vi- not only in revealing biological mechanisms underlying high-acuity sual system and its functions and also serve as important tools vision but also in the development of therapies. Successful trans- for studying the brain (5–8). lation of basic research findings into clinical trials and, moreover, approval of the first therapies for blinding inherited and age- Uniqueness of the Primate Model for Human Vision related retinal dystrophies has been reported in recent years.
  • Clinical and Molecular Genetic Aspects of Leber's Congenital

    Clinical and Molecular Genetic Aspects of Leber's Congenital

    Clinical and Molecular Genetic Aspects 10 of Leber’s Congenital Amaurosis Robert Henderson, Birgit Lorenz, Anthony T. Moore | Core Messages of about 2–3 per 100,000 live births [119, 50]. ∑ Leber’s congenital amaurosis (LCA) is a It occurs more frequently in communities severe generalized retinal dystrophy which where consanguineous marriages are common presents at birth or soon after with nystag- [128]. mus and poor vision and is accompanied by a nonrecordable or severely attenuated ERG 10.1.1 ∑ As some forms are associated with better Clinical Findings vision during childhood and nystagmus may be absent, a wider definition is early LCA is characterized clinically by severe visual onset severe retinal dystrophy (EOSRD) impairment and nystagmus from early infancy with LCA being the most severe form associated with a nonrecordable or substantial- ∑ It is nearly always a recessive condition but ly abnormal rod and cone electroretinogram there is considerable genetic heterogeneity (ERG) [32, 31, 118]. The pupils react sluggishly ∑ There are eight known causative genes and and, although the fundus appearance is often three further loci that have been implicated normal in the early stages,a variety of abnormal in LCA/EOSRD retinal changes may be seen. These include pe- ∑ The phenotype varies with the genes ripheral white dots at the level of the retinal pig- involved; not all are progressive. At present, ment epithelium, and the typical bone-spicule a distinct phenotype has been elaborated pigmentation seen in retinitis pigmentosa. for patients with mutations in RPE65 Other associated findings include the ocu- ∑ Although LCA is currently not amenable to lodigital sign, microphthalmos, enophthalmos, treatment, gene therapy appears to be a ptosis, strabismus, keratoconus [28], high re- promising therapeutic option, especially fractive error [143],cataract,macular coloboma, for those children with mutations in RPE65 optic disc swelling, and attenuated retinal vas- culature.
  • Progressive Cone and Cone-Rod Dystrophies

    Progressive Cone and Cone-Rod Dystrophies

    Br J Ophthalmol: first published as 10.1136/bjophthalmol-2018-313278 on 24 January 2019. Downloaded from Review Progressive cone and cone-rod dystrophies: clinical features, molecular genetics and prospects for therapy Jasdeep S Gill,1 Michalis Georgiou,1,2 Angelos Kalitzeos,1,2 Anthony T Moore,1,3 Michel Michaelides1,2 ► Additional material is ABSTRact proteins involved in photoreceptor structure, or the published online only. To view Progressive cone and cone-rod dystrophies are a clinically phototransduction cascade. please visit the journal online (http:// dx. doi. org/ 10. 1136/ and genetically heterogeneous group of inherited bjophthalmol- 2018- 313278). retinal diseases characterised by cone photoreceptor PHOTORECEPTION AND THE degeneration, which may be followed by subsequent 1 PHOTOTRANSDUCTION CASCADE UCL Institute of rod photoreceptor loss. These disorders typically present Rod photoreceptors contain rhodopsin phot- Ophthalmology, University with progressive loss of central vision, colour vision College London, London, UK opigment, whereas cone photoreceptors contain 2Moorfields Eye Hospital NHS disturbance and photophobia. Considerable progress one of three types of opsin: S-cone, M-cone or Foundation Trust, London, UK has been made in elucidating the molecular genetics L-cone opsin. Disease-causing sequence variants 3 Ophthalmology Department, and genotype–phenotype correlations associated with in the genes encoding the latter two cone opsins University of California San these dystrophies, with mutations in at least 30 genes
  • Novel Compound Heterozygous Mutations Resulting in Cone

    Novel Compound Heterozygous Mutations Resulting in Cone

    Letters seemed to be dark. The narrowing of the retinal vessels and disc 2. Kline LB, Kelly CL. Ocular migraine in a patient with cluster headaches. pallor diminished gradually over time. In the late phase of the Headache. 1980;20(5):253-257. attack (after 1 minute 28 seconds), the retinal vessels were di- 3. Winterkorn JMS, Kupersmith MJ, Wirtschafter JD, Forman S. Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl lated and the disc was hyperemic. Video 2 and Video 3 show J Med. 1993;329(6):396-398. the reperfusion of the retinal circulation in the late phase. The 4. Bernard GA, Bennett JL. Vasospastic amaurosis fugax. Arch Ophthalmol. images obtained immediately after the attack (Figure 2) show 1999;117(11):1568-1569. the dilated retinal vessels in the right eye. The images show that 5. Hill DL, Daroff RB, Ducros A, Newman NJ, Biousse V. Most cases labeled as the retinal veins and arteries in the right eye were more di- “retinal migraine” are not migraine. J Neuroophthalmol. 2007;27(1):3-8. lated than those in the left eye (not shown) or those obtained 6. Petzold A, Islam N, Plant GT. Video reconstruction of vasospastic transient under normal conditions 1 month after the attack. monocular blindness. N Engl J Med. 2003;348(16):1609-1610. No hypercoagulability was identified with hematologic and serologic testing. Findings on neurologic tests and magnetic Novel Compound Heterozygous Mutations Resulting resonance imaging of the brain were normal. The patient was in Cone Dystrophy With Supernormal Rod Response treated with propranolol hydrochloride because of an allergy Cone dystrophy with supernormal rod response (CDSRR) to lomerizine hydrochloride, and the retinal migraines have (RCD3B, OMIM #610356) was first described in 2 siblings by not recurred.
  • Annotation Cone and Cone-Rod Dystrophies

    Annotation Cone and Cone-Rod Dystrophies

    J Med Genet 1992: 29: 289-290 289 Annotation J Med Genet: first published as 10.1136/jmg.29.5.289 on 1 May 1992. Downloaded from Cone and cone-rod dystrophies The retinal dystrophies are a genetically het- examination is usually normal. Two main erogeneous group of disorders which may be forms are recognised. In complete achroma- seen as an isolated ocular abnormality or may topsia (rod monochromatism) there are no be associated with other systemic disease. In functioning cone photoreceptors in the retina.4 most disorders the underlying disease mechan- Vision is reduced to the level of about 6/60, ism is not known, so that classification is un- there is no true colour perception, and there satisfactory. There is great clinical heterogen- are normal rod but absent cone responses on eity even among dystrophies which share a electroretinography. Inheritance is autosomal common mode of inheritance. At present, dys- recessive but there may be more than one trophies are most usefully classified according form. Incomplete achromatopsia or blue cone to whether they are stationary or progressive monochromatism is an X linked recessive dis- and whether there is predominantly macular order which presents in a similar fashion but or generalised retinal disease. The latter group has a better visual prognosis.58 Colour vision is subdivided on the basis of whether there is testing and electroretinography show evidence involvement of rod or cone photoreceptors or of normal rod and blue cone function but both. Most disease is progressive and even- absent red and green cone responses."' tually involves both types of photoreceptors.